Close

Anti-Peptide ASQ T cell receptor ((Tg4)-2), pCDTCR1 (TCR-YC0887)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The T cell receptor (TCR) clone is specific for the NH2-terminal peptide Ac1-11[4A] of the autoantigen myelin basic protein in the context of major histocompatibility complex [MHC] class II molecule I-Aᵘ. The TCR may be used to explore the mechanism of soluble peptide therapy.

Specific Inquiry

  • Size:
  • Marker:
  • Form:
  Add to Cart

Details

  • Target
  • Peptide ASQ
  • Epitope
  • ASQARPSQRHG + ACET(A1)
  • Format
  • Non-Modified TCR
  • Allele
  • H-2Aᵘ
  • Vector Name
  • pCDTCR1
  • Vector Length
  • ~ 8 kb
  • Vector Type
  • Lentiviral vector
  • TCR Clone
  • Tg4
  • Host Species
  • Mouse

Target

  • Introduction
  • EAE has been successfully treated with the immunodominant epitope of MBP, Ac1-11, as well as analogues in which position four is changed from the native lysine to an alanine (Ac1-11[4A]) or tyrosine (Ac1-11[4Y]). Ac1-11[4A] and Ac1-11[4Y] bind to the MHC with ∼50 and 1,500 times higher affinity than does Ac1-11, and both peptides stimulate most Ac1-11–specific T cells more efficiently than does Ac1-11. The affinities of these peptides for I-Au correlate with the half-lives of each of the peptides complexed to I-Aᵘ; Ac1-11/I-Aᵘ has an immeasurably short half-life, Ac1-11[4A] has a half-life of ∼10 min, and Ac1-11[4Y]/I-Au can be detected for as long as 10 h. The efficacy of treatment of EAE with these three peptides correlates with the affinity of the peptides for I-Aᵘ. The mechanism of this treatment may be due to anergy, deletion, a switch in Th subset, or a combination of these phenomena.

Customer Reviews and Q&As

There are currently no customer reviews or questions for Mouse anti-Peptide ASQ T cell receptor ((Tg4)-2), pCDTCR1 (TCR-YC0887). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.